Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ENPCNASDAQ:MITANASDAQ:OACCNASDAQ:RENE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeENPCExecutive Network Partnering$5.98+0.3%$5.32$8.46▼$10.24$251.24M-0.04245,839 shs657,123 shsMITAColiseum Acquisition$11.51$11.51$9.00▼$13.70$63.73M0.0321,272 shsN/AOACCOaktree Acquisition Corp. III Life Sciences$10.59$10.36$9.95▼$10.85$237.48MN/A116,247 shs11 shsRENECartesian Growth Co. II$11.75$11.83$11.26▼$11.95$254.05M-0.0195,512 shs1 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceENPCExecutive Network Partnering+0.34%+2.22%+5.65%+3.64%-5.68%MITAColiseum Acquisition0.00%0.00%0.00%0.00%+5.02%OACCOaktree Acquisition Corp. III Life Sciences0.00%+0.57%+1.24%+4.75%+1,058,999,900.00%RENECartesian Growth Co. II0.00%0.00%+0.64%-0.42%+4.17%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationENPCExecutive Network PartneringN/AN/AN/AN/AN/AN/AN/AN/AMITAColiseum AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/AN/AN/ARENECartesian Growth Co. IIN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceENPCExecutive Network Partnering 0.00N/AN/AN/AMITAColiseum Acquisition 0.00N/AN/AN/AOACCOaktree Acquisition Corp. III Life Sciences 0.00N/AN/AN/ARENECartesian Growth Co. II 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookENPCExecutive Network PartneringN/AN/A$0.02 per share268.01($0.20) per shareN/AMITAColiseum AcquisitionN/AN/A$0.37 per share31.40($0.69) per shareN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/ARENECartesian Growth Co. IIN/AN/A$0.40 per share29.45($0.64) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateENPCExecutive Network Partnering$1.47MN/A0.004.18N/AN/A-74.23%-2.27%N/AMITAColiseum Acquisition$3.10MN/A0.00∞N/AN/A-16.55%-9.51%N/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/A0.00∞N/AN/AN/AN/AN/ARENECartesian Growth Co. II$11.44MN/A0.00∞N/AN/A-51.08%5.43%8/13/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthENPCExecutive Network PartneringN/AN/AN/AN/AN/AMITAColiseum AcquisitionN/AN/AN/AN/AN/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/ARENECartesian Growth Co. IIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioENPCExecutive Network PartneringN/A0.020.02MITAColiseum AcquisitionN/A0.010.01OACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/ARENECartesian Growth Co. IIN/A0.090.09Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipENPCExecutive Network Partnering88.58%MITAColiseum Acquisition25.79%OACCOaktree Acquisition Corp. III Life SciencesN/ARENECartesian Growth Co. II58.96%Insider OwnershipCompanyInsider OwnershipENPCExecutive Network Partnering0.17%MITAColiseum Acquisition47.70%OACCOaktree Acquisition Corp. III Life SciencesN/ARENECartesian Growth Co. II26.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableENPCExecutive Network Partnering142.01 million41.94 millionNot OptionableMITAColiseum Acquisition2,0215.54 million3.35 millionNot OptionableOACCOaktree Acquisition Corp. III Life SciencesN/A22.43 millionN/AN/ARENECartesian Growth Co. II221.62 million15.87 millionNot OptionableMITA, RENE, ENPC, and OACC HeadlinesRecent News About These CompaniesPolar Asset Management Partners Inc. Sells 142,000 Shares of Cartesian Growth Co. II (NASDAQ:RENE)May 19, 2025 | marketbeat.comCartesian Growth Corp II extends business combination periodMarch 5, 2025 | investing.comCartesian Growth Corp II extends business combination deadlineFebruary 5, 2025 | msn.comPositive Buy Rating for Cartesian Therapeutics Amid Encouraging Developments in Descartes-08 TrialsJanuary 28, 2025 | markets.businessinsider.comCartesian Growth Corporation IIDecember 23, 2024 | investing.comBertrand P. Grabowski's Net WorthNovember 2, 2024 | benzinga.comRENE’s Unexpected Plunge: What’s Next?October 31, 2024 | bovnews.comHow to Take Advantage of moves in (RENE)August 22, 2024 | news.stocktradersdaily.comMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeApple Stock Could Rally After Tariffs Are Blocked By CourtBy Gabriel Osorio-Mazilli | May 30, 2025View Apple Stock Could Rally After Tariffs Are Blocked By CourtTaiwan Semiconductor: Time to Buy After Strong NVIDIA Results?By Gabriel Osorio-Mazilli | May 30, 2025View Taiwan Semiconductor: Time to Buy After Strong NVIDIA Results?Intel's Price Spikes: Noise, or the First Notes of a Turnaround?By Jeffrey Neal Johnson | June 13, 2025View Intel's Price Spikes: Noise, or the First Notes of a Turnaround?Boeing Landed New Deals With China and the Saudis for More UpsideBy Gabriel Osorio-Mazilli | May 20, 2025View Boeing Landed New Deals With China and the Saudis for More UpsideMITA, RENE, ENPC, and OACC Company DescriptionsExecutive Network Partnering NYSE:ENPC$5.98 +0.02 (+0.34%) As of 06/13/2025Executive Network Partnering Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar partnering transaction with one or more businesses. The company was incorporated in 2020 and is based in Boston, Massachusetts.Coliseum Acquisition NASDAQ:MITA$11.51 0.00 (0.00%) As of 06/13/2025Coliseum Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Las Vegas, Nevada.Oaktree Acquisition Corp. III Life Sciences NASDAQ:OACC$10.59 0.00 (0.00%) As of 06/13/2025Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.Cartesian Growth Co. II NASDAQ:RENE$11.75 0.00 (0.00%) As of 05/13/2025Cartesian Growth Corp. II operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on October 13, 2021 and is headquartered in New York, NY. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/09 - 06/13 Alphabet Enters a Bull Market: Is It Time to Buy? Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones RH Stock Rockets on Surprise Profit and Tariff Shift Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
